Patel KP - Search Results

1

Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML.

Short NJ, Daver N, Dinardo CD, Kadia T, Nasr LF, Macaron W, Yilmaz M, Borthakur G, Montalban-Bravo G, Garcia-Manero G, Issa GC, Chien KS, Jabbour E, Nasnas C, Huang X, Qiao W, Matthews J, Stojanik CJ, Patel KP, Abramova R, Thankachan J, Konopleva M, Kantarjian H, Ravandi F. Short NJ, et al. Among authors: patel kp. J Clin Oncol. 2024 May 1;42(13):1499-1508. doi: 10.1200/JCO.23.01911. Epub 2024 Jan 26. J Clin Oncol. 2024. PMID: 38277619 Clinical Trial.

2

Acute myeloid leukemia with IDH1 or IDH2 mutation: frequency and clinicopathologic features.

Patel KP, Ravandi F, Ma D, Paladugu A, Barkoh BA, Medeiros LJ, Luthra R. Patel KP, et al. Am J Clin Pathol. 2011 Jan;135(1):35-45. doi: 10.1309/AJCPD7NR2RMNQDVF. Am J Clin Pathol. 2011. PMID: 21173122 Free PMC article.

3

Impact of numerical variation in FMS-like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemia.

Borthakur G, Kantarjian H, Patel KP, Ravandi F, Qiao W, Faderl S, Kadia T, Luthra R, Pierce S, Cortes JE. Borthakur G, et al. Among authors: patel kp. Cancer. 2012 Dec 1;118(23):5819-22. doi: 10.1002/cncr.27571. Epub 2012 May 17. Cancer. 2012. PMID: 22605576 Free PMC article.

4

Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay.

Verma S, Greaves WO, Ravandi F, Reddy N, Bueso-Ramos CE, O'Brien S, Thomas DA, Kantarjian H, Medeiros LJ, Luthra R, Patel KP. Verma S, et al. Among authors: patel kp. Am J Clin Pathol. 2012 Jul;138(1):153-6. doi: 10.1309/AJCPL0OPXI9LZITV. Am J Clin Pathol. 2012. PMID: 22706871 Free PMC article.

5

TdT expression in acute myeloid leukemia with minimal differentiation is associated with distinctive clinicopathological features and better overall survival following stem cell transplantation.

Patel KP, Khokhar FA, Muzzafar T, James You M, Bueso-Ramos CE, Ravandi F, Pierce S, Medeiros LJ. Patel KP, et al. Mod Pathol. 2013 Feb;26(2):195-203. doi: 10.1038/modpathol.2012.142. Epub 2012 Aug 31. Mod Pathol. 2013. PMID: 22936064 Free PMC article.

6

Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML.

Takahashi K, Jabbour E, Wang X, Luthra R, Bueso-Ramos C, Patel K, Pierce S, Yang H, Wei Y, Daver N, Faderl S, Ravandi F, Estrov Z, Cortes J, Kantarjian H, Garcia-Manero G. Takahashi K, et al. Leukemia. 2013 Oct;27(10):2081-3. doi: 10.1038/leu.2013.165. Epub 2013 Jun 7. Leukemia. 2013. PMID: 23774633 No abstract available.

7

Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia.

Ok CY, Hasserjian RP, Fox PS, Stingo F, Zuo Z, Young KH, Patel K, Medeiros LJ, Garcia-Manero G, Wang SA. Ok CY, et al. Leukemia. 2014 Jan;28(1):185-9. doi: 10.1038/leu.2013.191. Epub 2013 Jun 21. Leukemia. 2014. PMID: 23787392 No abstract available.

8

JAK2 p.V617F detection and allele burden measurement in peripheral blood and bone marrow aspirates in patients with myeloproliferative neoplasms.

Takahashi K, Patel KP, Kantarjian H, Luthra R, Pierce S, Cortes J, Verstovsek S. Takahashi K, et al. Among authors: patel kp. Blood. 2013 Nov 28;122(23):3784-6. doi: 10.1182/blood-2013-07-515676. Epub 2013 Sep 25. Blood. 2013. PMID: 24068492 Free PMC article.

9

Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with acute myeloid leukemia treated with hypomethylating agents.

DiNardo CD, Patel KP, Garcia-Manero G, Luthra R, Pierce S, Borthakur G, Jabbour E, Kadia T, Pemmaraju N, Konopleva M, Faderl S, Cortes J, Kantarjian HM, Ravandi F. DiNardo CD, et al. Among authors: patel kp. Leuk Lymphoma. 2014 Aug;55(8):1925-9. doi: 10.3109/10428194.2013.855309. Epub 2014 Feb 4. Leuk Lymphoma. 2014. PMID: 24138309 Free PMC article. No abstract available.

10

BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS.

Zhang L, Singh RR, Patel KP, Stingo F, Routbort M, You MJ, Miranda RN, Garcia-Manero G, Kantarjian HM, Medeiros LJ, Luthra R, Khoury JD. Zhang L, et al. Among authors: patel kp. Am J Hematol. 2014 May;89(5):499-504. doi: 10.1002/ajh.23652. Epub 2014 Feb 10. Am J Hematol. 2014. PMID: 24446311 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

607 results

Search Page